MedPath

Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators

Phase 3
Completed
Conditions
Arrhythmia
Interventions
Registration Number
NCT00035490
Lead Sponsor
Forest Laboratories
Brief Summary

Implantable cardioverter defibrillators (ICDs) have been developed to treat ventricular tachycardia or fibrillation (abnormal heart rhythms) by electrical shock or by pacing the heart. ICD therapy is established as highly effective for stopping life-threatening arrhythmias, but it does not preclude the use of anti-arrhythmic drugs for prevention and to decrease the frequency of ICD shocks.

The safety and effectiveness of oral azimilide dihydrochloride in reducing the frequency of ICD shocks has been investigated previously in a placebo-controlled study in patients with ICDs. These results need to be confirmed in this larger double-blind, placebo-controlled study with approximately 600 patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
633
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1placeboPlacebo tablets
2Azimilide Dihydrochloride75 mg azimilide
3Azimilide Dihydrochloride125 mg azimilide
Primary Outcome Measures
NameTimeMethod
Reducing the recurrence of all-cause shocks plus symptomatic ATPone year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (142)

The Heart Group

🇺🇸

Mobile, Alabama, United States

Tri-City Cardiology Consultants, P.C.

🇺🇸

Mesa, Arizona, United States

UAMS Dept of Cardiology

🇺🇸

Little Rock, Arkansas, United States

ATC/Cardio Medical Grp

🇺🇸

Beverly Hills, California, United States

Loma Linda Univ. Med. Ctr.

🇺🇸

Loma Linda, California, United States

Good Samaritan Hospital

🇺🇸

Los Angeles, California, United States

VA Greater Los Angeles Healthcare System

🇺🇸

Los Angeles, California, United States

Regional Cardiology Associates

🇺🇸

Sacramento, California, United States

Cardiac Arrythmia Associates

🇺🇸

San Diego, California, United States

UCSD Medical Center

🇺🇸

San Diego, California, United States

Scroll for more (132 remaining)
The Heart Group
🇺🇸Mobile, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.